Comparative care for IBD in Hispanic patients
Official title: Comparative effectiveness research in Hispanic patients with inflammatory bowel diseases
Funded at Mayo Clinic Arizona · NIH-11467869 · Data updated 2026-11-12
A Mayo Clinic Arizona team will study how Crohn’s disease and ulcerative colitis progress and respond to treatments in Hispanic patients using real-world data.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | January 18, 2024 |
| Project end | November 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $656,552 |
| NIH project number | 7R01DK135937-03 |
| Project ID | NIH-11467869 on NIH RePORTER |
Who could benefit from this research
✓Could help
Hispanic adults diagnosed with Crohn’s disease or ulcerative colitis who receive real-world care and have available health data.
✕Less likely to help
Patients not represented in the data sources or without access to care may not see direct benefits.
What this research studies
This project will use large patient data from real-world settings to understand how social, structural, and biological factors influence IBD outcomes in Hispanic people. The team will examine patterns of disease, treatments, and safety of targeted immunomodulator therapies to see what helps or harms patients in everyday care. By focusing on disparities in access and outcomes, the study aims to inform clinicians on choices that improve management for Hispanic patients with IBD. The research combines epidemiology with real-world comparative effectiveness using diverse data sources to guide personalized care.
Why it matters
Potential benefit: If successful, this work could help clinicians make better, more equitable treatment decisions for Hispanic patients with IBD.
How similar studies have gone: Previous real-world studies in IBD have shown variable treatment outcomes across populations, highlighting the need for focused analyses in Hispanic patients.
Where this research is happening
-
Mayo Clinic Arizona
Scottsdale, United States Active
Researchers
- Principal investigator: Singh, Siddharth — Mayo Clinic Arizona
- Study coordinator: Singh, Siddharth
Related research
Other NIH-funded projects on the same topics.
-
Understanding why some people with inflammatory bowel disease fail therapy
A physician-scientist at UNC is pursuing why inflammatory bowel disease treatment stops working so therapies can be kept effective longer.
-
Celiac and IBD: unlocking how genes influence disease with DNA methylation
A research project aims to use genetic and epigenetic clues to better understand why celiac disease and inflammatory bowel disease affect people differently and how they respond to treatment.
-
How genes and DNA changes influence celiac disease and inflammatory bowel disease
This project looks for DNA changes that alter gene activity to help predict risk, severity, and treatment response for people with celiac disease and inflammatory bowel disease.
-
Understanding what triggers inflammation in inflammatory bowel diseases
This study is looking at what causes inflammation in people with Crohn's disease and ulcerative colitis who are feeling really well, to help find ways to keep them healthy and prevent flare-ups in the future.
-
Finding ways to block bacterial enzymes that worsen inflammatory bowel diseases
This project looks for new ways to treat inflammatory bowel diseases like Crohn's and ulcerative colitis by targeting specific enzymes made by gut bacteria.
-
Using nanoparticles to deliver epigenetic treatments for inflammatory bowel diseases
This study is exploring a new way to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease by using tiny particles to deliver special medicines that can help reduce inflammation in your colon, aiming for a treatment that works better and has fewer side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.